Rheumatology 2001: Vol 40 Index

25 Pages·2001·6.7 MB·English

BRITISH JOURNAL OF RHEUMATOLOGY —~ GENERAL INDEX — VOLUME 40
E = Editorial: L Letter to the Editor
AARVAK T see Shadidi KR Amos N see Lawson TM
ABBAS D see Madan S Amyloidosis
ABBS I sec Godfrey I in Behget’s disease. A reappraisal of, 212
Abdominal aortic aneurysm with lumbar vertebral erosion in Behcet's in a series of 964 Portuguese rheumatoid arthritis patients: comment
disease revealed by low back pain: a case report and review of the on the article by Myllykangas-Luosujirvi et a/., (L) 944, (L) 945
literature, (L) 472 ANA and anti-dsDNA antibodies for flares in SLE. The predicitive value
ABELES M see Furst DE of, (L) 1422
ABOUZAHIR A see El Maghraoui A \naemia of systemic lupus erythematosus. Decreased serum erythropoietin
Acalculous cholecystitis and cardiac tamponade in a patient with drug- and its relation to anti-erythropoietin antibodies in, 424
induced lupus. Acute, (L) 709 Analgesics. Re: NSAIDS and simple. (L) 945
Acquired hypophosphataemic osteomalacia: the perils of missed a diagnosis. ANDERSON N see McGarry I
A severe case of, (L) 707 ANDO S see Nawata M
Acromioclavicular cyst and ‘porcupine shoulder’ in gout, (L) 1320 ANDONEGUI J see Cuende I
AbDEBAJO AO see Webb LH ANDRE MH sce Girard T
Adhesion molecule expression. Successful treatment of rheumatoid arthritis ANprRES E, GorcHor B, PERRIN A-E, Vinzio S, DEMANGEAT C, SCHLIENGER
is associated with a reduction in synovial membrane cytokines and J-L. Sjégren’s syndrome: a potential new aetiology of mild cobalamin
cell, 965 deficiency, (L) 1196
Adrenal haematoma in Henoch-Schénlein purpura, (L) 717 ANDREWS B see Furst DE
ADYEL F-Z see Hadj Kacem H ANIC B see Swaak AJG
Age of onset of rheumatoid arthritis (RA) in individuals with sporadic and Ankle brachial pressure index in systemic sclerosis: influence of disease
familial RA. The influence of current cigarette smoking on the, (L) subtype and anticentromere antibody, 1102
1068. (L) 1069 Ankylosing spondylitis
AGHER R see Mahr A bone density, ultrasound measurements and body composition in
AHERN M see Pettit AR early, 882
AHERN MJ see Smith MD correlation between the immune responses to collagen type I, III, IV
AHMED S, IHARA K, KANEMITSU S, NAKASHIMA H, OrsuKA T, TSUZAKA K, and V and Klebsiella pneumoniae in patients with Crohn’s disease
Takeucu! T, Hara T. Association of CTLA-4 but not CD28 gene and, 15
polymorphisms with systemic lupus erythematosus in the Japanese a polymorphism within the interleukin | receptor antagonist (IL-1Ra)
population, 662 gene is associated with, 1359
AMED S see also Harari OA Anti-B, glycoprotein | antibodies in sera of 61 apparently healthy children
AHO K see Myllykangas-Luosujarvi R: Saila H at regular preventive visits. Anticardiolipin and, 565
AIDS. Poncet’s disease in a patient with, (L) 346 Anti-cytokine therapy in rheumatoid arthritis. WHO Collaborating Centre
AKkayY M see Korkmaz ¢ consensus Meeting on, 699
AKIYA K see Nishikai M Anti-fibrillarin antibodies in systemic sclerosis, 1157
AKOGLU T see Tokay S Anti-oestrogens, non-steroidal, inhibit the differentiation of synovial macro-
Aksu K, TURGAN N, OxseL F, Keser G, OzMEN D, KitargioGLu G phages into dendritic cells, 185
GimUspisG , BayINDIR O, DOGANAVSARGIL E. Hyperhomocysteinaemia Anti-Ro antibodies, maternal. A normal ECG at birth does not exclude
in Behcet's disease, 687 significant congenital cardiac conduction disease associated with, 939
AKTUGLU Y see Pamuk GI Anti-thymocyte globulin
AL-ALLAF AW, KHAN F, MoreLanpb J, Betcu JJF, PULLAR T. Investigation plus mycophenolate mofetil in recent-onset diffuse scleroderma, 84
of cutaneous microvascular activity and flare response in patients with in scleroderma, (L) 1192
fibromyalgia syndrome, 1097 Anti- TNF therapy, how many patients are eligible for, in the UK?. (L) 1416
-ALLAF AW, SANperS PA, OGsTON SA, Marks JS. A case-control study \nti-topoisomerase | antibody levels determined by ELISA in systemic
examining the role of physical trauma in the onset of rheumatoid sclerosis. Clinical significance of, 1135
arthritis, 262 Antibodies
-E1p W see Al-Mayouf SM against B,-GPI and cardiolipin in patients with systemic lupus eryth-
L-Mayour SM, AL-Erp W, BaHasri S, AL-Morapba S. Interstitial pneu- ematosus and primary antiphospholipid syndrome, and their clin-
monitis and air leakage in juvenile dermatomyositis, 588 ical associations. IgG subclass distribution of, 1026
-Moraba S see Al-Mayouf SM inst oxidized low-density lipoproteins in systemic sclerosis, 401
-SAFFAR Z see Chan ATY anaemia of systemic lupus erythematosus. Decreased serum erythro-
ARCON-SEGOVIA D, DRENKARD C, VILLA AR. Survival of Mexican patients poietin and its relation to anti-erythropoietin, 424
with systemic lupus erythematosus, (L) 228 to food antigens. A vegan diet free of gluten improves the signs and
BRICH H, FEUERBACH S, KASPRZAK P, GLUCK T, SCHOLMERICH J, MULLER symptoms of rheumatoid arthritis: the effects on arthritis correlate
LADNER U. Three-dimensiona! computed tomography for visualization with a reduction in, 1175
of carotid bypasses in Takayasu arteritis, (L) 235 Antibody design, and improving serotherapy with monoclonal antibodies
GRA A see de Nijs RNJ From bench to bedside: discovering rules for, 724
WOTAS J see Solans R Anticardiolipin and anti-B, glycoprotein | antibodies in sera of 61 apparently
LANORE Y, Borperir D, HILLIQUIN P, HERNVANN A, LEVACHER M, healthy children at regular preventive visits, 565
LEMARECHAL H, EKINDJIAN OG, KAHAN A. Low levels of nitric oxide Anticardiolipin antibodies in Behget’s disease: a reassessment, 192
(NO) in systemic sclerosis: inducible NO synthase production is Anticentromere antibody. Isolated digital infarction associated with, (L) 355
decreased in cultured peripheral blood monocyte macrophage cells, 1089 \ntineutrophil cytoplasmic antibodies (ANCA)
ALLARD S see Sharpe | are they a marker predictive of relapse in Wegener's granulomatosis?
ALNoT JY see Lefevre-Colau MM \ prospective study, 147
ALSTERGREN P see Nordahl S prevalence and spectrum of rheumatic diseases associated with pro-
ALTIPARMAK MR sce Melikoglu M teinase 3-antineutrophil cytoplasmic antibodies (ANCA) and
ALVADO G sce Legangneux I myeloperoxidase-, 178
ALVARADO DE LA BARRERA C see Pacheco-Tena C Antiphospholipid antibodies. Haemophagocytic syndrome in a antiphospho-
AMBROZIC A see Avcin 7 lipid syndrome patients with, (L) 828
AMENGUAL O see Caliz R Antiphospholipid syndrome
Amer H, Swan A, Dieppe P. The utilization of synovial fluid analysis in antiphospholipid syndrome secondary to systemic lupus erythematosus
the UK, 1060 (SLE) and SLE alone. Comparison of renal disease severity and
American College of Rheumatology systemic sclerosis trial guidelines on outcome in patients with primary, 863
the nature of systemic sclerosis patients entering a clinical trial. Effects haplotype analysis in 83 Caucasoid patients. HLA class II gene poly-
of the, 615 morphisms in, 31
Ames PRJ, Steuer A, Pap A, DENMAN AM. Thrombosis in Behget’s disease: in systemic sclerosis, (L) 111
a retrospective survey from a single UK centre, 652 Antiphospholipid syndrome, primary. IgG subclass distribution of anti-
Amirva RI see Pacheco-Tena C bodies against B,-GPI and cardiolipin in patients with systemic lupus
AMOR-Dorabo JC see Garcia-Porrua C erythematosus and, and their clinical associations, 1026
GENERAL INDEX
ANTONEN J see Hulkkonen J ATsuMI T see Caliz R
AOKI H see Suzuki Y Au V see Pettit AR; Smith MD
A poptosis AULELEY G-R, Ducue A, Drape J-L, DouGapos M, Ravaup P.
of Jurkat Tc ells in culture. Monoclonal antibodies against human Measurement of joint space width in hip osteoporosis: influence of joint
ribosomal P proteins penetrate into living cells and cause, 750 positioning and radiographic procedure, 414
of normal human polymorphonuclear neutrophils. Monoclonal anti- Autoantibodies
double stranded DNA antibody is a leucocyte-binding protein to to the 27 C-terminal amino acids of calpastatin are detected in a
up-regulate interleukin-8 gene expression and elicit, 851] restricted set of connective tissue diseases and may be useful for
APPELBOOM T see Emery P diagnosis of rheumatoid arthritis in community cases of very early
ARAL O see Giil A arthritis, 1126
ARCHANE MI see El Maghraoui A to a 68/48 kDa protein in chronic fatigue syndrome and primary
ARDICOGLU O see Kamanli A fibromyalgia: a possible marker for hypersomnia and cognitive
ARINGER M, STUMMVOLL GH, STEINER G, KOLLER M, STEINER CW, HOFLER disorders, 806
E, HiesBERGER H, SMOLEN JS, GRANINGER WB. Serum interleukin-15 is Autoantibody profiles, nephritis-associated serum, in patients with systemic
elevated in systemic lupus erythematosus, 876 lupus erythematosus, an analysis of clinical disease activity and.: a
ARMADANSL sce Solans R cross-sectional study, 1405
ARNOLDI C see Gerloni V Autoimmune cholangitis. Juvenile idiopathic arthritis associated with auto-
Arteritis immune thyroid disorders and, 942
giant cell, is more prevalent in urban than in rural populations, (L) 1193 Autoimmune diseases. Intravenous immunoglobulin application following
Takayasu, three-dimensional computed tomography for visualization immunoadsorption: benefit or risk in patients with, 513
of carotid bypasses in, (L) 235 Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?, 102
temporal Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a
fever and dry cough in a patient with a prosthetic heart valve. An patient with primary Sjégren’s syndrome, (L) 948
interesting presentation of, (L) 714 Autoimmune thyroid disorders and autoimmune cholangitis. Juvenile idio-
survival in polymyalgia rheumatica and,: a study of 398 cases and pathic arthritis associated with, 942
matched population controls, 1238 Autologous stem cell transplantation for paediatric-onset polyarteritis
Arthritic joint diseases. Increased expression of the blood group-related nodosa: changes in autoimmune phenotype in the context of reduced
Lewis Y antigen on synovial fluid granulocytes of patients with, 1033 diversity of the T- and B-cell repertoires, and evidence for reversion
Arthritic temporomandibular joint, radiographic signs of bone destruction from the CD45RO~* to RA* phenotype, 1299
in, with special reference to markers of disease activity. A longitudinal Auzary C, Du Boutin LTH, WecHsLerk B, CHOLLET P, Piette JC.
study, 691 Disseminated nocardiosis presenting as a flare of Behcet's disease,
Arthritis (L) 949
adjuvant. The k-opioid agonist, asimadoline, alters cytokine gene AvcIn T, AMBRozIC A, KUHAR M, Kveper T, ROZMAN B. Anticardiolipin
expression in, 1013 and anti-B, glycoprotein I antibodies in sera of 61 apparently healthy
amelioration of rat antigen-induced, by liposomally conjugated metho- children at regular preventive visits, 565
trexate is accompanied by down-regulation of cytokine mRNA Awaya Y see Maeda H
expression, 375 AXFORD JS see Pool AJ
in children. British Paediatric Rheumatology Group News: Ayap! H see Hadj Kacem H
Management guidelines for arthritis, 1308, 1309 Azathioprine toxicity mimicking a relapse of Wegener’s granulomatosis,
familial erosive, associated with seroreactivity to human intracisternal (L) 831
retroviral particle type | (HIAP-I), (L) 227
patients. High in vivo expression of interleukin-17 receptor in synovial B.-GP1 and cardiolipin in patients with systemic lupus erythematosus and
endothelial cells and chondrocytes from, 522 primary antiphospholipid syndrome. IgG subclass distribution of anti-
peripheral, the prevalence and incidence of, in patients with inflam- bodies against, and their clinical associations, 1026
matory bowel disease, a prospective population-based study B19, human parvovirus, infection in patients with systemic lupus
(IBSEN ), 1256 erythematosus, 152
prolonged, associated with Sindbis-related (Pogosta) virus infection, B cell, autologous stem cell transplantation for paediatric-onset polyarteritis
(L) 1319 nodosa: changes in autoimmune phenotype in the context of reduced
therapy: a better time, a better day, (E) 603 diversity of the T- and, repertoires, and evidence for reversion from the
very early, autoantibodies to the 27 C-terminal amino acids of calpa- CD45RO* to RA“ phenotype. 1299
statin are detected in a restricted set of connective tissue diseases B lymphocytes. Sustained improvement in rheumatoid arthritis following a
and may be useful for diagnosis of rheumatoid arthritis in commun- protocol designed to deplete, 205
ity cases of, 1126 BaBA H see Wada M
wolf in sheep’s clothing? Extra domain-positive fibronectins in, (E) 721 Back pain
Arthroplasty. Physical exercise and risk of severe knee osteoarthritis a case of post-coital. Sacral insufficiency fracture, (L) 1065
requiring, 432 see also Low back pain
Arthroscopic subacromial surgery in inflammatory arthritis of the BACON PA see Wilson AS
shoulder, 384 Bacterial DNA in synovial fluid cells of patients with juvenile onset
Articular cartilage spondyloarthropathies, 920
the relationship of the compressive modulus of, with its deformation BADER-MEUNIER B see Stéphan JL
response to cyclic loading: does cartilage optimize its modulus so BAHABRI S see Al-Mayouf SM
as to minimize the strains arising in it due to the prevalent loading BAHLOUL Z see Hadj Kacem H
regime?, 274 BaIN GI see Haynes DR
under tensile cyclic load. Mechanical behaviour of, 13 3a BALADA E see Villarreal J
ArTLETT CM, MILLER FW, Riper LG. Persistent maternally derived peri- BAMMANN F see Kuemmerle-Deschner JB
pheral microchimerism is associated with the juvenile idiopathic BANK RA see Ronday HK
inflammatory myopathies, 1279 BANKEN L see Hemmings FJ
ARUMANAYAGAM M see Tam LS Banyal S see Schmaldienst S
ASANO Y see Yamane K Barak A sce Leibovitch I
Asimadoline, the k-opioid agonist, alters cytokine gene expression in BARBER J, BUTLER RC, Davie MWJ, Sewry CA. Hypoparathyroidism
adjuvant arthritis, 1013 presenting as myopathy with raised creatine kinase, (L) 1417
ASMUSSEN K see Bowman SJ BARBIERI L see Parodi A
ASMUSSEN KH, BowMAN SJ. Outcome measures in Sjégren’s syndrome, BARBIN L sec Spisani S$
(E) 1085 BarGy F see Lefevre-Colau MM
ASSMANN G see Schotte H BARKER MK, SEEDHOM BB. The relationship of the compressive modulus of
Association articular cartilage with its deformation response to cyclic loading: does
of CTLA-4 but not CD28 gene polymorphisms with systemic lupus cartilage optimize its modulus so as to minimize the strains arising in
erythematosus in the Japanese population, 662 it due to the prevalent loading regime?, 274
and linkage disequilibrium between a novel polymorphism in the BARNSLEY L see Hassett G
transforming growth factor $ gene and hip bone mineral density: BarR W see Furst DE
a study of female twins. Evidence of, 48 BARRERA P see Radstake TRDJ
ATKINS GJ see Haynes DR BARRETT J see Hewlett S
GENERAL INDEX
BarreETT JC see Kolettas | special reference to markers of disease activity. A longitudinal
BaRuFFO A see La Montagna G study, 691 :
Bas S, Muzzin P, Fucpius T, Bucus N, ViscHer TL. Indirect evidence of by rheumatoid synovium. Osteoclast-like cells in an in vitro model
intra-articular immunoglobulin G synthesis in patients with Chlamydia of, 673
trachomatis reactive arthritis, 801 Bone mineral density
BASSINGHAM D see Harley D bone turnover, joint damage and. in early rheumatoid arthritis treated
Basso M see Filaci G with combination therapy including high-dose prednisolone, 1231
BatTEGAY M see Maclachlan D hip, evidence of association and linkage disequilibrium between a novel
BayTNbDIR O see Aksu K polymorphism in the transforming growth factor B gene and.: a
BECQ-GIRAUDON B see Landron C study of female twins, 48
Behcet's disease in Marfan syndrome, (L) 358, (L) 359
abdominal aortic aneurysm with lumbar vertebral erosion in, revealed static alignment and dynamic load, relationship among, in patients with
by low back pain: a case report and review of the literature, (L) 472 medial compartment knee osteoarthritis, 499
amyloidosis in, a reappraisal of, 212 Bone morphogenic protein-2 (BMP-2), involvement of, in the pathological
anticardiolipin antibodies in, a reassessment, 192 ossification process of the spinal ligament, 1163
disseminated nocardiosis presenting as a flare of, (L) 949 Bone turnover, joint damage and bone mineral density in early rheumatoid
hyperhomecysteinaemia in, 687 arthritis treated with combination therapy including high-dose predniso-
lack of association of HLA-B*5/ with a severe disease course in, 668 lone, 1231
recalcitrant orogenital ulceration of, treatment with infliximab, (L) 473 BoNNEFOY M see Landron( ¢
systemic Nocardia infection in a patient with, (L) 597 Bootsma H see van de Loosdrecht AA
thrombosis in, a retrospective survey from a single UK centre, 652 BoRALDI F see Pasquali Ronchetti |
Borperie D see Allanore Y
in UK children: clinical features and treatment including thalidomide,
933 BoscH JA see Solans R
BeLcu JJF see Al-Allaf AW Bowen MA see Ramos-Casals M
BELL S see Weber A BowMaN SJ, PiLLEMER S, JONSSON R, AsMUSSEN K, ViTactt C, MANTHORPE
Bell test and the hyperextension test, value of the, for diagnosis in sciatica R, Sutcuirre N. Revisiting Sjégren’s syndrome in the new millennium
associated with disc herniation: comparison with Laségue’s sign and perspectives on assessment and outcome measures. Report of a work-
the crossed Laségue’s sign, 460
shop held on 23 March 2000 at Oxford, UK, 1180
BELLASTELLA A see La Montagna G BowMaN SJ see also Asmussen KH; Douglas K
BetLucci G and SeEDHOM BB. Mechanical behaviour of articular cartilage BRANNEMARK § see Hafstrém |
under tensile cyclic load, 1337 BREEDVELD FC see Emery P: Ronday HK: Vos K
Be_t EA see Lehtinen JT BREKKE M, HsortpAne P, Kvien TK. Self-efficacy and health status in
BEN SEDRINE W, RADICAN L, REGINSTER J-Y. On conducting burden-of- rheumatoid arthritis: a two-year longitudinal observational study, 387
osteoporosis studies: a review of the core concepts and practical issues BRESNIHAN B see Cunnane G; Kane D
\ study carried out under the auspices of a WHO Collaborating BREWIN CR see Sharpe |
Centre, 7 BRIDGER S see Tiwana H
Ben-AmMI H see Rozin A British Paediatric Rheumatology Group News, 563
Ben-Cuetrit E, Saci M. Genetic counselling in familia! Mediterranean Management guidelines for arthritis in children, 1308, 1309
fever: has the time come?, (E) 606 British Society for Rheumatology. A joint initiative for joint problems
BeNITEZ-Brito R see Tiwana H how to manage demand. Royal College of General Practitioners and,
Benzie IFF see Tam LS (L) 833
Beppu M see Suzuki Y Brooks P, HocHBERG M. Outcome measures and classification criteria for
BERESFORD JN see Walsh S the rheumatic diseases. A compilation of data from QOMERACT
BERGAMINI G see Pasquali Ronchetti | (Outcome Measures for Arthritis Clinical Trials), ILAR (International
BERTAZZOLO N see Punzi L League of Associations for Rheumatology), regional leagues and other
BERTOUCH JV see Katrib A groups, 896
Bezza A see El Maghraoui A Brown N, Ruys-DILLON CCG, Martin JC. Isolated digital infarction
BHANJI A see Pyne D associated with anticentromere antibody, (L) 355
BuLsMa JWJ see de Nijs RNJ Bruce IN, SILMAN AJ. The aetiology of psoriatic arthritis, (E) 363
BINYMIN K, Cooper RG. Late reactivation of spinal tuberculosis by low- BRuYN GAW see de Nijs RNJ
dose methotrexate therapy in a patient with rheumatoid arthritis, Bicut S see Stoll T
(L) 341 Bucus N see Bas S
Bionpt ML see Marasini B BUCKNALL RC see Chan ATY
BirD H see Grahame R BULGEN D see Lawson TM
BirD HA see Reilly KA BUNN CC see Tormey VJ
BIRMINGHAM TB, KRAMER JF, KinKLEY A, INGLIS JT, SPAULDING SJ, Burden-of-osteoporosis studies, on conducting,: a review of the core concepts
and practical issues. A study carried out under the auspices of a WHO
VANDERVOORT AA. Knee bracing for medial compartment osteoarthritis:
effects on proprioception and postural control, 285 Collaborating Centre, 7
BirRELL F, Crorr P, Cooper C, Hoste G, MACFARLANE G, SILMAN A. BurGE P see Williamson |
Predicting radiographic hip osteoarthritis from range of movement, 506 BuRGOS-VARGAS R see Pacheco-Tena €
BiyiKLt M see Yazici H BuRKE MJ see Vilches A
Burnet S. MAHADEVAN G, Lee A, RISCHMUELLER M. Sacral insufficiency
Bizzaro N, VILLALTA D. The predictive value of ANA and anti-dsDNA
antibodies for flares in SLE, (L) 1422 fracture—a case of post-coital back pain, (L) 1065
BusH KA, KirKHAM BW, Wa ker JS. The x-opioid agonist, asimadoline,
BLack A see Chrubasik S
alters cytokine gene expression in adjuvant arthritis, 1013
BLack CM see Cherkas LF: Coleiro B: MacGregor AJ; Stratton RJ; BUTLER RC see Barber J
Tormey VJ
ByRON M see Kirwan J
BLANN A see Coleiro B
BLeEUMINK GS, ter BorG EJ, RAMSELAAR CG, STRICKER BHCh. Etanercept- C-reactive protein (CRP), pyrexia and normal, in patients with systemic
induced subacute cutaneous lupus erythematosus, (L) 1317 lupus erythematosus: always consider the possibility of infection in
Blood group-related Lewis Y antigen on synovial fluid granulocytes of febrile patients with systemic lupus erythematosus regardless of CRP
patients with arthritic joint diseases. Increased expression of the, 1033 levels, (L) 349
Body composition in early ankylosing spondylitis. Bone density, ultrasound Cabergoline, prolactin antagonist, control of unremitting rheumatoid arth-
measurements and, 882 ritis by the, (L) 237
Boers M see Verhoeven AC CaILLEUX N see Marie |
BOMBARDIERI S see Swaak AJG CALAMBRUN C see Stephan JI
Bone densitometry. Incidental detection of lumbar Paget's disease by, Calcific tendinitis mimicking acute sternoclavicular joint arthritis, (L) 1316
(L) 1424 Cauiz R, Atsumt T, Konpeatis E, AMENGUAL O, KHAMASHTA MA,
Bone density, ultrasound measurements and body composition in early VAUGHAN RW, Lancusury JS, HuGHes GRV. HLA class Il gene
ankylosing spondylitis, 882 polymorphisms in antiphospholipid syndrome: haplotype analysis in 83
Bone destruction Caucasoid patients, 31
in the arthritic temporomandibular joint, radiographic signs of, with CALLENDER ME see Walsh SJ
ERAL INDEX
Calpastatin, autoantibodies to the 27 C-terminal amino acids of, are detected CGAN B see Rolf CG
in a restricted set of connective tissue diseases and may be useful for CHAMBERLAIN MA see Frank AO: Gilworth G; Tennant A
diagnosis of rheumatoid arthritis in community cases of very early CHAMEAU A-M see Landron C
arthritis, 1126 CHAN ATY, AL-SAFFarR Z, BUCKNALL RC. Thyroid disease in systemic lupus
Catvo J see Ramos-Casals M erythematosus and rheumatoid arthritis, (L) 353
CAMBRIDGE G see Edwards JCW CHARCOT, JEAN-MARTIN, ALFRED BARING GARROD. Nosology versus patho-
CaMICIOTTOLI G see Trapani S logy. two approaches to rheumatic diseases illustrated by, 467
Campylobacter infection. Focal myositis due to, (L) 704 CuenHata JC, Hassett AB, CLARKE SA, Mattey DL, Jones MA, Jones PW,
CANAVAN R see MacGregor AJ Dawes PT. Mortality in rheumatoid arthritis: relationship to single and
Cane S see Honorati MC composite measures of disease activity, 447
CANHAO H see Fonseca JE Chemokines and matrix metalloproteinases in early rheumatoid arthritis
CANTALEJO M see Mufhoz-Fernandez S Expression of, 988
Cao Y see Mendez EA CHERIAN AM sce Rose AR
CapeLt HA sec Hamilton JD; McEntegart A CHERKAS LF, Howeve K, Carter L, BLACK CM, MacGrecor AJ. The use
Cardiac conduction disease, significant congenital, associated with maternal of portable radiometry to assess Raynaud’s phenomenon: a practical
anti-Ro antibodies. A normal ECG at birth does not exclude, 939 alternative to thermal imaging, 1384
Cardiac tamponade in a patient with drug-induced lupus. Acute acalculous CHESELDINE DC see Wilson AS
cholecystitis and, (L) 709 CHEVREL G, JeENvRIN C, MCGREGOR B, Miossec P. Renal type AA amyl-
Cardiolipin, antibodies against B,-GP1 and, in patients with systemic lupus oidosis associated with rheumatoid arthritis: a cohort study showing
erythematosus and primary antiphospholipid syndrome, IgG subclass improved survival on treatment with pulse cyclophosphamide, 821
distribution of, and their clinical associations, 1026 Childhood. Benign joint hypermobility in, (E) 489
Cardiovascular disease, rheumatoid arthritis and, may share similar risk Childhood Myositis Heterogeneity Collaborative Study Group, 1279
factors, (L) 703, (L) 704 Childhood periodic fever with hyperimmunoglobulinaemia D. Clinical and
Cardiovascular involvement in systemic lupus erythematosus patients with molecular variability in, 579
non-specific chest complaints. The role of technetium-99m_ sestamibi Children
myocardial perfusion single-photon emission computed tomography anticardiolipin and anti-$, glycoprotein I antibodies in sera of 61
(SPECT) in the detection of, 1106 apparently health, at regular preventive visits, 565
Cardiovascular risk factors, including thrombotic variables, in a population Behget’s disease in UK, clinical features and treatment including
with rheumatoid arthritis, 640 thalidomide, 933
CaRIANI A see Spisani S$ British Paediatric Rheumatology Group News: Management guidelines
Carotoid bypasses in Takayasu arteritis. Three-dimensional computed tomo- for arthritis in, 1308, 1309
graphy for visualization of, (L) 235 with extended oligoarticular juvenile idiopathic arthritis. Hereditary
Carpal tunnel syndrome. Diagnosis of, (L) 595, (L) 596 predisposition to low interleukin-10 production in, 574
Carro_t GJ, Ma DT. Effective control of incomplete reactive arthritis with measuring the function of, with juvenile arthritis, 1274
cyclosporin, (L) 945 reactive haemophagocytic syndrome in, with inflammatory disorders.
CARRUTHERS DM sce Wilson AS A retrospective study of 24 patients, 1285
Carsons S. Extra domain-positive fibronectins in arthritis: wolf in sheep's time to take hypermobility seriously (in adults and), (E) 485
clothing?, (E) 721 Chlamydia trachomatis reactive arthritis. Indirect evidence of intra-articular
CarTeR L see Cherkas LI immunoglobulin G synthesis in patients with, 801
Cartilage Cuol JH see Han CW
does it optimize its modulus so as to minimize the strains arising in it Cholesterol ratio as a potential risk factor for corticosteroid-induced
due to the prevalent loading regime? The relationship of the osteonecrosis in rabbits. A high low-density lipoprotein cholestrol to
compressive modulus of articular cartilage with its deformation high-density lipoprotein, 196
response to cyclic loading:, 274 “HOLLET P see Auzary C
mechanical behaviour of articular, under tensile cyclic load, 133 ‘hondrocyte phenotype and cell survival are regulated by culture conditions
ultrasonic measurement of thickness of human, in situ by Yao and and by specific cytokines through the expression of Sox-9 transcription
Seedhom, comment on, (L) 829 factor, 1146
Cartilage oligomeric matrix protein, cytokines, metalloproteinases, theit hondrocytes from arthritis patients. High in vivo expression. of
inhibitors and,: relationship to radiological progression and inflamma- interleukin-17 receptor in synovial endothelial cells and, 522
tion in early rheumatoid arthritis. A prospective 5-year study, 544 hromium-5]! ethylenediamine tetraacetic acid glomerular filtration rate: a
Cartilage proteoglycan degradation, human granzyme B mediates. and is better predictor than glomerular filtration rate calculated by the
expressed at the invasive front of the synovium in rheumatoid arth- Cockcroft-Gault formula for renal involvement in systemic lupus
ritis, 55 erythematosus patients, 324
Casari S see Marasini B hronic fatigue syndrome and primary fibromyalgia, autoantibodies to a
CaTTepDU | see Inoue K 68/48 kDa protein in,: a possible marker for hypersomnia and cognitive
(sCDS and sCD6) in patients with primary Sjégren’s syndrome. High disorder, 806
circulating levels of soluble scavenger receptors, 1056 hronic widespread pain, risk factors for persistent.: a community-based
(CD32), FeyRIla polymorphism in Spanish systemic lupus erythematosus study, 95
patients. Mannose binding lectin and, 1009 HRUBASIK S, KUNZEL O, MopeLt A, ConpRADT C, BLACK A. Treatment of
CD45RO* to RA® phenotype. Autologous stem cell transplantation for low back pain with a herbal or synthetic anti-rheumatic: a randomized
paediatric-onset polyarteritis nodosa: changes in autoimmune pheno- controlled study. Willow bark extract for low back pain, 1388
type in the context of reduced diversity of the T- and B-cell repertoires, HUNG WY see Tam LS
and evidence for reversion from the, 1299 ‘HUNG Y-L see Miller FW
CD180(RP105) in rheumatic diseases. (L) 1315 ‘hurg-Strauss syndrome: outcome and long-term follow-up
Cell proliferation, increased, and associated expression of PDGFRB6 causing patients, 763
hypercellularity in patella tendinosis. 256 “HWALINSKA-SADOWSKA H see Swaak AJG
‘ell survival, chondrocyte phenotype and, are regulated by culture condi- ‘IFUENTES-ALVARADO M_ sce Pacheco-Tena C
tions and by specific cytokines through the expression of Sox-9 transcrip- ‘igarette smoking
tion factor, 1146 the influence of current, on the age of onset of rheumatoid arthritis
entral nervous system complications in two cases of juvenile onset dermato- (RA) in individuals with sporadic and familial RA, (L) 1068,
myositis, 1293 (L) 1069
‘erebrospinal fluid biogenic amine metabolites, plasma-rich platelet sero- and severity of rheumatoid arthritis, (L) 1426
tonin and [*HJimipramine reuptake in the primary fibromyalgia syn- ‘IKES N see Swaak AJG
drome, 290 ‘IMAZ R see Gerloni V
"ERVERA R see Ramos-Casals M “LARKE AB see Chehata JC
‘ervical myelopathy, rheumatoid, factors predictive of subsequent deterior- LARKE AE see Sutcliffe N
ation in, 811 ‘lassification criteria, outcome measures and, for the rheumatic diseases. A
‘ervical spine disorders, mortality associated with.: a population-based compilation of data from OMERACT (Outcome Measures for Arthritis
study of 1666 patients with rheumatoid arthritis who died in Finland Clinical Trials), ILAR (International League of Associations for
in 1989, 123 Rheumatology), regional leagues and other groups, 896
‘ervicobrachial pain that is treated conservatively. The association of the ‘LEARY AG, Sitts JA, Davipson JE, CoHen AM. Reflex sympathetic
involvement of financial compensation with the outcome of, 552 dystrophy, 590
GENERAL INDEX
CLEMENTS PJ see Furst DI responses to collagen type I. HII, IV and V and Ale/
Clinical. radiological and synovial immunopathological responses. asociation in patients with, 15
of, to anti-rheumatic treatment in rheumatoid arthritis. 1243 ROSDALE D see Villarreal J
Clinical trial. Effects of the American College of Rheumatology systemic roTTI TN see Haynes DR
sclerosis trial guidelines on the nature of systemic sclerosis patients SERNOK E see Schénermarck |
entering a, 615 TLA-4, HLA-DQBI CARI CAR2 and TNFa IR2 IR4 polym
Cobalamin deficiency, mild. Sjégren’s syndrome: a potential new aetiology Tunisian patients with rheumatoid arthritis and Sjégret
of, (L) 1196 7 1370
Cochin rheumatoid hand disability scale. responsiveness of the, after UADRADO MJ see Godfrey 1
surgery, 843 UELLO C see Katrib A
CocksHoTT Z see Hewlett S UENDE E, Ruiz Mena A, ANDONEGUI J. MINGUELA I. VesGA Ocular
CoGGon D. Reply to Helliwell PS, Taylor WJ. (L) 716 involvement in Wegener's granulomatosis responding to intravenous
COGHLAN J see MacGregor AJ cyclophosphamide, (L) 1066
COHEN AM sce Cleary AG UNNANE G, MADIGAN A, Murpuy E, FirzGeratp O. BResNIHAN B. The
CouHen AP, McWilliams TG. Reply to Rothschild ef a/.. (L) 707 effects of treatment with interleukin-| receptor antag on the
Colchicine for the treatment of recurrent Henoch—-Sch6nlein purpura in an inflamed synovial membrane in rheumatoid arthritis, 62
adult, (L) 1430 utaneous lupus erythematosus. subacute. etanercept-induced. ( L)
Coceiro B, MARSHALL SE, DENTON CP, HoweLt K, BLANN A, WetsH KI, utaneous microvascular activity and flare response in patients with
BLack CM. Treatment of Raynaud’s phenomenon with the selective myalgia syndrome. Investigation of. 1097
serotonin reuptake inhibitor fluoxetine, 1038 UTOLO M see Filaci G
COLEMAN M see Smith MD yclophosphamide
Collagen intravenous. ocular involvement in Wegener's granulomatosis
increased urinary pyridinoline cross-link compounds of, in patients with responding to, (L) 1066
systemic sclerosis and Raynaud’s phenomenon, 140 pulse, renal type AA amyloidosis associated with rheumatoid arthritis
type I, IIL, IV and V and Alehsiella pneumoniae, correlation between a cohort study showing improved survival on treatment with. 821
the immune responses to, in patients with Crohn’s disease and yclosporin A
ankylosing spondylitis, 15 effective control of incomplete reactive arthritis with, (L) 945
Collagenase-selective inhibitor Trocade'™, tolerability and pharmacokinetics efficacy and safety profile of. in the treatment of juvenile chronic
of the, in patients with rheumatoid arthritis, 537 (idiopathic) arthritis. Results of a 10-year prospective study. 907
CoLLiER D see Furst DI inhibition of neutrophil responses by nto molecular mechan
Colour Doppler ultrasound of the nailbed: an objective tool for monitoring isms, 794
responses to vasodilatory treatment of connective tissue disorders?, long-term treatment of patients affected by systemic sclerosis with
(L) 954 (L) 1431
Combined central retinal artery and vein occlusion in a patient with systemic Cytokine(s)
lupus erythematosus, (L) 1195 and cell adhesion molecule expression, synovial membrane. successful
Compartment syndrome, chronic exertional, of the forearms secondary to treatment of rheumatoid arthritis is associated with a reduction
weight training, (L) 344 in, 965
Compressive modulus of articular cartilage, the relationship of the. with its chondrocyte phenotype and cell survival are regulated by culture
deformation response to cyclic loading: does cartilage optimize its conditons and by specific. through the expression of Sox-9 tran-
modulus so as to minimize the strains arising in it due to the prevalent scription factor, 1146
loading regime?, 274 elevated serum levels in a rheumatoid arthritis patient with large
Computed tomography findings in a patient with rheumatoid arthritis granular lymphocyte syndrome, (L) 592
Gold-induced pneumonitis:, (L) 712 gene expression in adjuvant arthritis. The k-opioid agonist, asimadoline
CONAGHAN PG see Quinn MA alters, 1013
ConbDRADT C see Chrubasik S and immunogenetic profiles in Japanese patients with adult Sull’s
Congenital cardiac conduction disease, significant, associated with maternal disease. Association with chronic articular disease. | 3*
anti-Ro antibodies. A normal ECG at birth does not exclude, 939 metalloprotemases. their inhibitors and cartilage
Connective tissue disease. undifferentiated, and primary biliary cirrhosis protein: relationship to radiological prog
Superficial calcinosis related to bleeding in a patien. with, (L) 947 in early rheumatoid arthritis. A prospective 5-year study, 544
Connective tissue disorders, colour Doppler ultrasound! of the nailbed: an mRNA expression. Amelioration of rat antigen-induced arthritis
objective tool for monitoring responses to vasodilatory treatment of liposomally conjugated methotrexate accompanied by
(L) 954 regulation of
Connective tissue panniculitis. Lipodystophy and, (L) pattern after stress exposure. Systemic lupus e
Construct validity of the Disease Repercussions Profile in people with toid arthritis patients differ from healthy controls in
rheumatoid arthritis. Evidence for inadequate, 757 play an aetiopathogenetic role in fibromyalgia I
Consultant nurses in rheumatology: releasing the potential!, (E) 1325 study. 743
Coombs positivity, autoimmune neutropenia, thrombocytosis and, see also Inflammatory cytokine(s)
patient with primary Sjégren’s syndrome, (L) 948 CziRJAK L see Stok R
Cooper C see Birrell I
Cooper R see Miller FW D’ Amico E see De Santis D: Palazzi ¢
Cooper RG see Binymin K DAN P see Nitzan DW
CorbiER JF see Girard 1 Danba D see Rose AR
Corticosteroid-induced osteonecrosis in rabbits. A high low-density lipo- Danko K see Miller FW
protein cholesterol to high-density lipoprotein cholesterol ratio as a DANNECKER GE see Kuemmerle-Deschner JB
potential risk factor for, 196 Das SK see Ramakrishnan $
Costa Dias F sce Fonseca Jt Davar J see MacGregor AJ
Costs, total, and predictors of costs in patients with systemic lupus eryth- Davipson JE see Cleary AG: Dawson JK
ematosus, 37 Davie MW)J see Barber J
CourTtNEY PA, PATTERSON RN, Lee RJE. Henoch-Schénlein purpura tollow- Davies KA see Samarkos M
ing meningitis C vaccination, (L) 345 Dawes PT see Chehata JC: Jordan K
Courtots H see Marie | Dawson JK. Davipson JE. Focal myositis due to Cur obacter infection,
CRAWLEY E, Kon S, Woo P. Hereditary predisposition to low interleukin-10 (L) 704
production in children with extended oligoarticular juvenile idiopathic Dawson JK see also Earnshaw SM
arthritis, 574 Dayer J-M see also Roux-Lombard P
Creatine kinase, raised. Hypoparathyroidism presenting as myopathy with, D’Cruz D see also Kawsar M
(L) 1417 Dr JonG Z see also TijhuisG J
Creep F see Dickens € Dre Nuss RNJ, Jacoss JWG, Burtsma JWJ, Lems WF. LAAN RFJM,. Housen
CRERAN D see McEntegart A HHM. ter BorG EJ, Huisman AM. Bruyn GAW, van Ouren PLM,
Cricoarytenoid joint involvement, bilateral, in rheumatoid arthritis: a case Westcerst AAA, ALGRA A, Horman DM. Prevalence ef vertebral
report, (L) 593 deformities and symptomatic vertebral fractures in corticosteroid treated
Crort P see Birrell F: Jinks C patients with rheumatoid arthritis, 1375
Crohn’s disease and ankylosing spondylitis. Correlation between the immune Dr Roos JADM see also Ronday HK
GENERAL INDEX
De Santis D, Patazzi C, D'Amico E, Di Mascio DE, Pacr-PAuitti V, Dvorak J see Mannion Al
Petrricca A. Acromioclavicular cyst and “porcupine shoulder’ in gout, Dysphagia and stridor caused by laryngeal rheumatoid arthritis, (L) 952
(L) 1320 Dzirpzic K see Jordan K
De Santis D see also Palazzi €
Dr Vrits RRP see Vos K E- and P-selectin, limited endothelial, expression in MRL//pr lupus prone
DeresoMCHOK U see Osiri M mice, 889
DEIGHTON C see Stevens KJ Early intervention, for rheumatoid arthritis, the therapeutic approach of,:
DELAMERE JP see Erb N what is the evidence? 1211
DeLmas PD sce Gineyts I EARNSHAW SM, MacGrecor G, Dawson JK. Fibromyalgia—monotheories,
DeMANGEAT C see Andres I monotherapies and reductionism, (L) 348
Dents P see Marie | EBERHARDT K_ see Roux-Lombard P
EBRINGER A sce Tiwana H
DENMAN AM. Anti-thymocyte globulin in scleroderma, (L) 1192
DeNHAM AM sce also Ames PRJ ECG, normal, at birth does not exclude significant congenital cardiac
DeNTON CP see Coleiro B; MacGregor AJ; Tormey VJ conduction disease associated with maternal anti-Ro antibodies, 939
EDA-containing fibronectin in synovial fluid, alternatively spliced, as a
Depression
in patients with rheumatoid arthritis. The burden of, (E) 1327 predictor of rheumatoid joint destruction, 739
in systemic lupus erythematosus patients, prediction of, using SF-36 EDELMANN E see Emery P
Mental Health scores, 695 Epoutr Y see Rozin A
Dercut L see Filaci G Educational-behavioural joint protection programme for people with
DeRFLER K see Schmaldienst S$ rheumatoid arthritis. One-year outcomes of a randomized controlled
Dermatomyositis trial of an, 1044
juvenile, interstitial pneumonitis and air leakage in, 588 Epwarps JCW. CampripGe G. Sustained improvement in rheumatoid
pneumomediastinum and subcutaneous emphysema associated with, arthritis following a protocol designed to deplete B lymphocytes, 205
EGucui K see Ozaki M
(L) 476
DrSaLvo KB see Mendez EA EKINDJIAN OG see Allanore Y
DesseIN PH, Stanwix AE, Moomat Z. Rheumatoid arthritis and cardio- Ev Kuattasi A see El Maghraoui A
vascular disease may share similar risk factors, (L) 703 Ev MaGuraout A, TABACHE F, EL KuHattast A, BEZZA A, ABOUZAHIR A,
DetrKe M, PALFr G, PurscH E, FiscHeR MB, LoipNer H. Increased GHaAFIR D, OHAYON V, ARCHANE MI. Abdominal aortic aneurysm with
expression of the blood group-related Lewis Y antigen on synovial fluid lumbar vertebral erosion in Behget’s disease revealed by low back pain:
granulocytes of patients with arthritic joint diseases, 1033 a case report and review of the literature, (L) 472
Elbow joints, rheumatoid, radiographic joint space in, a 15-year prospective
Dexamethasone, high concentrations of, suppress the proliferation but not
the differentiation or further maturation of human osteoblast precursors follow-up study in 74 patients, 1141
ELIAsson S see Nordahl S$
in vitro: relevance to glucocorticoid-induced osteoporosis, 74
ELISA in systemic sclerosis. Clinical significance of anti-topoisomerase |
Di Mascio DE sce De Santis D
antibody levels determined by, 1135
Dickens C and Creep F. The burden of depression in patients with Emery P, ReGinsteR J-Y, APPELBOOM T, BREEDVELD FC, EDELMANN E,
rheumatoid arthritis, (E) 1327 Kekow J. Maratse M, Moca EM, Montecucco C, SANDA M, SAny
Dieppe P. From protocols to principles, from guidelines to toolboxes: aids
to good management of osteoarthritis, (E) 841 J. Scorr DL, Serni U, Seypoux G. WHO Collaborating Centre
Dieppe P see also Amer H consensus meeting on anti-cytokine therapy in rheumatoid arthritis, 699
Digital infarction, isolated, associated with anticentromere antibody, (L) 355 Emery P see also Quinn MA
DILLON MJ see Kari JA EMO syndrome as a late explanation for pretibial swelling, (L) 357
Endothelial expression of HLA-DQ and interleukin I, increased, in extra-
DIRESKENELI H see Tokay S articular rheumatoid arthritis. Results from) immunohistochemical
Dise herniation, lumbar scoliosis associated with a, in an adult, (L) 1427
Disease activity studies of skeletal muscle, 1346
ENGLUND M, Roos EM, Roos HP, LOHMANDER LS. Patient-relevant out-
analysis of clinical, and nephritis-associated serum autoantibody profiles comes fourteen years after meniscectomy: influence of type of meniscal
in patients with systemic lupus erythematosus: a cross-sectional tear and size of resection, 631
study, 1405
ENGLUND P see Turesson C
mortality in rheumatoid arthritis: relationship to single and composite
Enthesopathy, tumoral, in psoriasis, (L) 342
measures of, 447 Eosiniphilic arthritis, human toxocariasis as a possible cause of, (L) 109
radiographic signs of bone destruction in the arthritic temporomandibu-
Ers N, Kitas GD. Homocysteine modulation as a reason for continuous
lar joint with special reference to markers of, a longitudinal folic acid supplementation in methotrexate-treated rheumatoid arthritis
study, 69] patients, (L) 715
Disease outcome assessment. proposed preliminary core set measures for,
N. Pace AV, DeLamere JP, Kitab GD. Control of unremitting
in adult and juvenile idiopathic arthritis myopathies, 1262
rheumatoid arthritis by the prolactin antagonist cabergoline, (L) 237
Disease Repercussions Profile ERB N, Pace AV, DeLamere JP, Kitas GD. Dysphagia and stridor caused
characteristics of handicap for patients with recent onset rheumatoid
by laryngeal rheumatoid arthritis, (L) 952
arthritis. The validity of, 1169 ErB N see also Pace AV
in people with rheumatoid arthritis. Evidence for inadequate construct
validity of the, 757 ERNST E sce | ong I
Espinoza LR see Mendez EA
Disseminated nocardiosis presenting as a flare of Behget’s disease, (L) 949 Etanercept-induced subacute cutaneous lupus erythematosus, (L) 1317
Dopps WN, IsenBERG DA. UK regional rheumatology meetings. (L) 1423 ETCHEPARE F see Lefevre-Colau MM
DOGANAVSARGIL E see Aksu K
EULAR Standing Committee on International Clinical Studies Including
Doscinov S see Williams AS Therapeutic Trials (ESCISIT ). Incomplete lupus erythematosus: results
DoMLJAN Z see Swaak AJG of a multicentre study under the supervision of the, 89
DomSCHKE W see Schotte H
Exercise
DouGapos M see Auleley G-R the effects of, on the hormonal and immune systems in rheumatoid
DouGLas K, BowMAN SJ. How many patients are eligible for anti-TNI arthritis, 610
therapy in the UK?, (L) 1416 physical, and risk of severe knee osteoarthritis requiring arthroplasty,
Dovico L see Spisani $ 432
Draper J-L see Auleley G-R: Poiraudeau S Extensor tendon rupture in rheumatoid arthritis. Screening for, 420
DRATWIANKA B see Swaak AJG Extra domain-positive fibronectins in arthritis: wolf in sheep’s clothing?,
DRENKARD C see Alarcon-Segovia D (E) 721
Drosera M see Parodi A
Drug-induced lupus. Acute acalculous cholecystitis and cardiac tamponade FABBRI E see Spisani S
in a patient with, (L) 709 FACCHINI A see Honorati MC
Dry cough, fever and, in a patient with a prosthetic heart valve. An FAIN O see Kubalek |
interesting presentation of temporal arteritis, (L) 714 FALCINI F see Trapani S
Du Boutin LTH see Auzary € Familial Mediterranean fever, genetic counselling in, has the time come?,
Ducue A see Auleley G-R (E) 606
Ducrorte P see Marie | FANTINI F see Gerloni V
Durry G see Kane D FARDELLON P see Inoue K
Duran M sce Frenkel J FARDELLONE P see Vittecog O
GENERAL INDEX
FAREWELL V see Miller FW FRIEDMAN Z see Yacobovich JR
FARHAN M sce Hemmings FJ FRIZz1ERO L see Honorati MC: Pasquali Ronchetti |
FeyRIla (CD32) polymorphism in Spanish systemic lupus erythematosus FRoeELICH CJ see Ronday HK
patients. Mannose binding lectin and, 1009 Frost C see Sutcliffe N
FERMANIAN J see Lefevre-Colau MM; Poiraudeau S Fu BSC see Rolf CG
FERREIRA A see Mufioz-Fernandez S Fut T, Nouma T, Yasuoka H, SatoH S, NAKAMURA K, KuWaNa M.
FEUERBACH S see Albrich H Suwa A, Hirakata M, Mimort T. Cytokine and immunogenetic profiles
FEUERHAKE F see Imgrund M in Japanese patients with adult Still’s disease. Association with chronic
Fever and dry cough in a patient with a prosthetic heart valve. An interesting articular disease, 1398
presentation of temporal arteritis, (L) 714 FukubDA H see Gotoh M
Fibromyalgia (syndrome), (L) 348 Fucpius T sce Bas S
monotheories, monotherapies and reductionism, (L) 348 Functional ability
cytokines play an aetiopathogenetic role in, a hypothesis and pilot of children with juvenile idiopathic arthritis. Discordance between
study, 743 proxy-reported and observed assessment of, 914
I mistake your shape, (L) 230 of Thai patients with rheumatoid arthritis by the use of a Thai version
investigation of cutaneous microvascular activity and flare response in of the Health Assessment Questionnaire.
patients with, 1097 FUREDER W see Schett G
primary FURLAN M see Giingér T
cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet FURONAKA O sce Maeda H
serotonin and [°H Jimipramine reuptake in the, 290 Furst DE, CLEMENTS PJ, WONG WK. Mayes MD, WiGLrey F, Wuite B.
a possible marker for hypersomnia and cognitive disorders WEISMAN M, Barr W. MoreLanp L, Martin R, MepsGer Jr TA
Autoantibodies to a 68/48 kDa protein in chronic fatigue STEEN V, CoLuieR D, Wernstein A, LALty E, VarGa J, Werner SR.
syndrome and, 806 ANDREWS B, ABELES M, Peter JB, Serpo_p JR. Effects of the American
Fibronectin(s) College of Rheumatology systemic sclerosis trial guidelines on the
in arthritis, extra-domain postitive,: wolf in sheep's clothing?, (E) 721 nature of systemic sclerosis patients entering a clinical trial, 615
in synovial fluid, alternatively spliced EDA-containing, as a predictor
of rheumatoid joint destruction, 739
Fibrosing alveolitis. Interstitial lung disease in patients with rheumatoid Garcia-Carrasco M see Ramos-Casals M
arthritis: a comparison with crytogenic, 1022 Garcta-PorruA C, AmMor-Dorapdo JC, Gonzacez-Gay MA. Unilaterz
FIEBIGER W, STUMMVOLL G, WEINLANDER G, RADERER. Does pantoprazole submandibular swelling as unique presentation of Wegener's granulom-
alleviate mouth dryness in patients with Sjégren’s syndrome, (L) 110 atosis, (L) 953
Firtp M see Gupta MN: McGarry I Garcia-RODRIGUEZ MC see Mufioz-Fernandez §
Firact G, Cutoto M, Basso M, Murpaca G, Dercut L, GIAnrossi R, GARNERO P see Gineyts I
Ropoto F, ZeNTILIN P, SuLtt A, Puppo F, INpivert F. Long-term GARROD, ALFRED BARING (1819-1907). 1189
treatment of patients affected by systemic sclerosis with cyclosporin A, and Jean-Martin Charcot. Nosology versus pathology, two approaches
(L) 1431 to rheumatic diseases illustrated by. 467
FireR A, HuGHes A, Kane K, Mutimer D, JoBANPUTRA P. Successful Garry RF see Mendez EA
treatment of hepatitis B-associated vasculitis using lamivudine as the GATTINARA M see Gerloni V
sole therapeutic agent, (L) 1064 Gausitz M see Schotte H
Financial compensation, the association of the involvement of, with the Gayet A see Vittecoqg O
outcome of cervicobrachial pain that is treated conservatively, 552 Genetic counselling in familial Mediterranean fever has the time come?.
FINDLAY DM see Haynes DR (E) 606
FirBas U see Schett G Geode, when is it not a geode: when LSMFT?, (L) 706
FiscH C, SCHILLER P, Harr T, MACLACHLAN D. First presentation of GERLONI V, Cimaz R, GATTINARA M, ARNOLDI C, PONTIKAKI I. FANTINI I
intestinal bypass syndrome 18 yr after initial surgery, (L) 351 Efficacy and safety profile of cyclosporin A in the treatment of juvenile
FISCHER MB see Dettke M chronic (idiopathic) arthritis. Results of a 10-year prospective study, 907
FISCHER R see Swaak AJG GEuSENS P see Verhoeven AC
FisHER P, Scott DL. A randomized controlled trial of homeopathy in GHaFiR D see El Maghraoui A
rheumatoid arthritis, 1052 Gianrossi R see Filaci G
FitZGERALD O see Cunnane G; Kane D; Patel S Giant cell arteritis
Flare of Behget’s disease. Disseminated nocardiosis presenting as a, (L) 949 is more prevalent in urban than in rural populations, (L) 1193
Flare response in patients with fibromyalgia syndrome. Investigation of see also Temporal arteritis
cutaneous microvascular activity and, 1097 GiBNEY R see Kane D
Flares in SLE. The predictive value of ANA and anti-dsDNA antibodies Gitroy CB, Keat A, TayLor-Ropinson D. The prevalence of Mycoplasma
for, (L) 1422 fermentans in patients with inflammatory arthrides, 1355
Fluoxetine. Treatment of Raynaud’s phenomenon with the selective sero- GitwortH G, HaiGH R, TENNANT A, CHAMBERLAIN MA, Harvey AR. Do
tonin reuptake inhibitor, 1038 rheumatologists recognize their patients’ work-related problems?, 1206
Focal myositis due to Campylobacter infection, (L) 704, (L) 705 Gineyts E, GarNnero P, Detmas PD. Urinary excretion of glucosyl-
Fort C see Godfrey T lactosyl pyridinoline: a specific biochemical marker of synovium
Folic acid supplementation, continuous, in methotrexate-treated rheumatoid degradation, 315
arthritis patients. Homocysteine modulation as a reason for, (L) 715 Girard T, Mawr A, Noét LH, Corpier JF, Lesavre P, ANDRE MH
FoLtz V see Poiraudeau S Guillevin L. Are antineutrophil cytoplasmic antibodies a marker pre-
Fonseca JE, CANHAO H, Costa Dias F, LEANDRO MJ, RESENDE C, TEIXEIRA dictive of relapse in Wegener's granulomatosis? A prospective study, 147
Da Costa JC, Pereira Da Sitva JA, VIANA Queiroz M. Amyloidosis Girard T see also Mahr A
in a series of 964 Portuguese rheumatoid arthritis patients: comment GLADMANN DD sce Urowitz MB
on the article by Myllykangas-Luosujirvi e7 a/l., (L) 944 Glomerular filtration rate, chromium-51 ethylenediamine tetraacetic acid,
Font J see Ramos-Casals M a better predictor than glomerular filtration rate calculated by the
FONTAN G see Munioz-Fernandez S Cockcroft-Gault formula for renal involvement in systemic lupus
Foot problems in patients with systemic sclerosis, 410 erythematosus patients, 324
Francois A see Marie | Gitck T see Albrich H
FRANK AO, CHAMBERLAIN MA. Keeping our patients at work: implications Glucocorticoid-induced osteoporosis. High concentrations of dexametha-
for the management of those with rheumatoid arthritis and mucsuloske- sone suppress the proliferation but not the differentiation or further
letal conditions, (E) 1201 maturation of human osteoblast precursors in vitro: relevance to, 74
FRANKE S see Kaufmann J Glucocorticoid-mediated repression of inflammatory cytokine production in
FRAZER TH see Pettit AR fibroblast-like rheumatoid synoviocytes is independent of nuclear
FREEMAN K see Hammond A factor-KB activation induced by tumour necrosis factor x, 26
FRENKEL J, Houten SM, WarerHaM HR, Wanpers RJA, Rukers GT, Glucosyl-galactosyl pyridinoline, urinary excretion of,: a specific biochemical
Duran M, Kuupers TW, van Luk W, Pott-THe BT, Kuts W. Clinical marker of synovium degradation, 315
and molecular variability in childhood periodic fever with hyperimmuno- Gluten, a vegan diet free of, improves the signs and symptoms of rheumatoid
globulinaemia D, 579 arthritis: the effects on arthritis correlate with a reduction in antibodies
Fresko | see see Melikoglu M to food antigens, 1175
FRIEDMAN J sce Klepfish A Gopparb MJ see Riley GP
GENERAL INDEX
Goprrey T, Cuaprapo MJ, Fort C, Apps 1, KHAMASHTO MA, NuNaNn T, HAMADA K see Gotoh M
HuGues GRV. Chromium-51 ethylenediamine tetraacetic acid glomer- HAMAGUCHI Y see Sato S
ular filtration rate: a better predictor than glomerular filtration rate HaMILTON JD, JOHNSTON RA, MADHOK R, CapeLt HA. Factors predictive
calculated by the Cockcroft-Gault formula for renal involvement in of subsequent deterioration in rheumatoid cervical myelopathy, 811
systemic lupus erythematosus patients, 324 HAMMOND A, FREEMAN K. One-year outcomes of a randomized controlled
GoicuoT B see Andres I trial of an educational-behavioural joint protection programme for
Gok U see Kamanli A people with rheumatoid arthritis, 1044
Gold-induced pneumonitis: computed tomography findings in a patient with HammoupeuH M. Calcific tendinitis mimicking acute sternoclavicular joint
rheumatoid arthritis, (L) 712 arthritis, (L) 1316
GOLDAMMER A see Schmaldienst S HAMURYUDAN V see Melikoglu M
GOLDSTEIN M sce Leibovitch I Han CW, Cuor JH, Kim JM, Kim WY, Lee KY, Ou GT. Glucocorticoid-
GomENI C see Legangneux I mediated repression of inflammatory cytokine production in fibroblast-
GoMEZ-ZUMAQUERO JM see Herrick Al like rheumatoid synoviocytes is independent of nuclear factor-«B activa-
Gonadotropin releasing hormone/thyroid-stimulating hormone stimulation tion induced by tumour necrosis factor %, 267
in women with systemic sclerosis. Assessment of pituitary gonadotropin HAN S-H sce Hsieh S-€
release to, 310 Hand disability scale, Cochin rheumatoid, responsiveness of the, after
GONZALEZ-Gay MA see Garcia-Porrua surgery, 843
Gora A see Gotsman | Hand X-rays of patients with rheumatoid arthritis. The relationship between
Gorbon C see Samarkos M soft tissue swelling, joint space narrowing and erosive damage in, 297
Gorpdon PA, KHAMASHTA MA, HuGHes GRV, RosentHaL E. A normal Hands, Jaccoud’s arthropathy of the, as a complication of pyrophosphate
ECG at birth does not exclude significant congenital cardiac conduction arthropathy, (L) 354
disease associated with maternal anti-Ro antibodies, 939 HANKINS RW see Nishikai M
GorRDON TE see Kalke S$ HANsEN BU see Oien RI
GotoH M, HaMaDA K. YAMAKAWA H, YANAGISAWA K, NAKAMURA M, HANSEN VK sce Rasmussen
YAMAZAKI H, UryaMA Y, TAMAOKIN, INOUE A, FUKUDA H. Interleukin- HAKANSSON A see Oien RI
l-induced subacromial synovitis and shoulder pain in rotator cufl Hag I, Morris V. Post-partum septic sacroiliitis, (L) 1191
diseases, 995 Hara T see Ahmed S; Koga Y
GOTSMAN I, Gora A, Nusair S. Secondary spontaneous pneumothorax in Harari OA, MarsHact D, McHace JF, AHMED S, HAsKARD DO. Limited
a patient with pulmonary rheumatoid nodules during treatment with endothelial E-and P-selectin expression in MRL//pr lupus prone mice,
methotrexate, (L) 350 889
Gout HarBorD M sce Tiwana H
acromioclavicular cyst and ‘porcupine shoulder’ in, (L) 1320 HaRDINGHAM TE sce Kolettas I
spinal cord compression: an unusual neurological complication of. HARKER SD see Webb LH
(L) 711 Hartey D, BassinGHAM D, SLEIGH A. Prolonged arthritis associated with
GRAHAME R, Birp H. British consultant rheumatologists’ perceptions about Sindbis-related (Pogosta) virus infection, (L) 1319
the hypermobility syndrome: a national survey, 559 Harr T see Fisch C
GRAHAME R. Time to take hypermobility seriously (in adults and children), Harris § see Wilson AS
(E) 485 HARRISON B see Symmons D
Gran JT, Mykcesust G, WiILsGAARD T, JACOBSEN BK. Survival in poly- Harvey AR see Gilworth G
myalgia rheumatica and temporal arteritis: a study of 398 cases and HaseGAWA M _ see Nishijima C: Sato S
matched population controls, 1238 HasHimMoTo H see Nawata M
GRAN JT see also Palm O HaskarD DO see Harari OA
GRANINGER W sce Swaak AJG
Hastock I see Hewlett S
GRANINGER WB see Aringer M HasseLt AB see Chehata JC
Granzyme B, human, mediates cartilage proteoglycan degradation and Hassett G, BARNSLEY L. Pain referral from the sternoclavicular joint: a
is expressed at the invasive front of the synovium in rheumatoid study in normal volunteers, 859
arthritis, 55 HaTFiELD R see St George |
GREANEY T see Kane D Hau M see Keberle M
GRIFFIN K see Sari-Kouzel H Hay E. Royal College of General Practitioners and British Society for
Gross WL see Reinhold-Keller E; Schénermarck |
Rheumatology. A joint initiative for joint problems — how to manage
GuERRA D see Pasquali Ronchetti I demand, (L) 833
GUILLEVIN L see Girard T; Mahr A Hay EM see Price EJ
Gt A, Uyar A, INANC M, Ocal L, TUGAL-TUTKUN I, ARAL O, Konige M, Haynes DR, Crotti TN, Loric M, Batn GI, Atkins GJ, FINDLAY DM.
SARUHAN-DiRESKENELI G. Lack of association of HLA-B*5/] with a
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand
severe disease course in Behget’s disease, 668 (RANKL) regulate osteoclast formation by cells in the human rheuma-
GiUspis G see Aksu K
toid arthritic joint, 623
GUNGOR T, FURLAN M, LAMMLE B, KUHN F, SeGer RA. Acquired deficiency HAZENBERG MP see Schrijver [A
of von Willebrand factor-cleaving protease in a patient suffering from Hazes JMW see Tijhuis GJ; Vos K
acute systemic lupus erythematosus, 940 HAZLEMAN BL sce Riley GP
Gupta MN, Sturrock RD, Firtp M. A prospective 2-year study of 75 Health Assessment Questionnaire. Evaluation of functional ability of Thai
patients with adult-onset septic arthritis, 24 patients with rheumatoid arthritis by the use of a Thai version of the, 555
GuRLEY-GREEN S. Living with the hypermobility syndrome, (E) 487 Health status, self-efficacy and, in rheumatoid arthritis: a two-year longitud-
inal observational study, 387
Hacuiya M see Ohno M HEeUNEN CJ see Jacobs R
Hack CE see Ronday HK HEIN G see Kaufmann J
Hap) Kacem H, Kappour N, Apyet F-Z, BanLtout Z, Ayapi H. HeELIGVAARA M see Manninen P
HLA-DQBI CARI/CAR2, TNFa IR2/IR4 and CTLA-4 polymorph- He_tiweit PS, Taytor WJ. Occupation and upper limb disorders, (L) 716
isms in Tunisian patients with rheumatoid arthritis and Sjégren’s HELLIWELL PS see a/so Knights LR
syndrome, 1370 HemMincs FJ, FARHAN M, ROWLAND J, BANKEN L, JAIN R. Tolerability
Haemophagocytic syndrome in a systemic lupus erythematosus patients and pharmacokinetics of the collagenase-selective inhibitor Trocade'™
with antiphospholipid antibodies, (L) 828 in patients with rheumatoid arthritis, 537
HarstrOM I, RINGERTZ B, SPANGBERG A, von ZWEIGBERGK L, BRANNEMARK Henoch-Sch6énlein purpura
S, NYLANDER I, RONNELID J, LAASONEN L, KLARESKOG L. A vegan diet adrenal haematoma in, (L) 717
free of gluten improves the signs and symptoms of rheumatoid arthritis: colchicine for the treatment of recurrent, in an adult, (L) 1430
the effects on arthritis correlate with a reduction in antibodies to food following meningitis C vaccination, (L) 345
antigens, 1175 HENRIKSEN JE see Shadidi KR
HaiGH R see Gilworth G; Tennant A HeENSELMANS JML sce van de Loosdrecht AA
Haseer A see Villarreal J Hepatitis, autoimmune, and systemic sclerosis: a new overlap syndrome?, 102
HaKALA M see Myllykangas-Luosujirvi R Hepatitis B-associated vasculitis, successful treatment of, using lamivudine
HAKAN T see Korkmaz C as the sole therapeutic agent, (L) 1064, (L) 1065 |
HALLeGua D see Wallace DJ HrpBpuRN A, PaNnpir N. Focal myositis due to Campy/dbacter infection
Hacsry JP see Varireddy S Reply, (L) 705 oe
GENERAL INDEX
HEPBURN AL. The LE cell, 826 Elevated interleukin-6 plasma levels are regulated by the promoter
Herbal medicines for the treatment of osteoarthritis: a systematic review. 7 9 region polymorphism of the /L6 gene in primary Sjégren’s syndrome
Herbal or synthetic anti-rheumatic, treatment of low back pain with a: a and correlate with the clinical manifestations of the disease, 656
randomized controlled study. Willow bark extract for low back pain, Hutt RG. British Paediatric Rheumatology Group News: Management
1388 guidelines for arthritis in children, 1308, 1309
HERNVANN A see Allanore Y Human intracisternal retroviral particle type | (HIAP-I). Familial erosive
Herrick AL, ILLiInGwortH KJ, Hottis S$, Gomez-ZUMAQUERO JM, arthritis associated with seroreactivity to, (L) 227
TINAHONES FJ. Antibodies against oxidized low-density lipoproteins in Human leukocyte antigen see HLA
systemic sclerosis, 401 Human parvovirus B19 infection in patients with systemic lupus eryth-
Herrick AL see also Sari-Kouzel H: Wan MC ematosus, 152
HERROU M see Legangneux I Human toxocariasis as 4 possible cause of eosinophilic arthritis, (L) 109
HEUFELDER AE see Hofbauer LC Hunt IM see McBeth J
Hewrett S, CocksHott Z, Kirwan J, Barrett J, Stamp J, Hastock | HURME M see Hulkkonen J
Development and validation of a self-efficacy scale for use in British HUTCHINSON CE see Sari-Kouzel H
patients with rheumatoid arthritis (RASE), 1221 HutcHinson D, LyncH MP, Moots RJ, THompson RN, Wittiams E. The
HICKLING P see Robertson LP influence of current cigarette smoking on the age of onset of rheumatoid
HiksBeRGER H see Aringer M; Schett G arthritis (RA) in individuals with sporadic and familial RA, (L) 1068
HILLIER CEM sce St George f HutcHinson D, Moots R. Cigarette smoking and severity of rheumatoid
HILLIQUIN P see Allanore Y arthritis, (L) 1426
Hino K see Shiozawa K Hyaluronic acid, the role of, in protecting surface-active phospholipids from
Hip bone mineral density. Evidence of association and linkage disequilibrium lysis by exogenous phospholipase A,. 336
between a novel polymorphism in the transforming growth factor B Hydropneumothorax, spontaneous. in a man with rheumatoid arthritis,
gene and,: a study of female twins, 48 (L) 232
Hip osteoarthritis, predicting radiographic, from range of movement, 506 Hydrotherapy, prophylactic, (E) 4
Hip osteoporosis, influence of joint positioning and radiographic procedure. Hypercalcaemia due to Lowe’s syndrome, identical twins with, (L) 107
Measurement of joint space width in, 414 Hyperextension test. the bell test and, for diagnosis in sciatica associated
Hip Study Group, PCR, 506 with disc herniation: comparison with Laségue’s sign and the crossed
HIRAKATA M see Fujii 7 Laségue’s sign. Value of, 460
Hirata A see Nishijima C Hyperhomocysteinaemia in Behget’s disease, 687
HJjoRTDAHL P see Brekke M Hyperimmunoglobulinaemia D. Clinical and molecular variability in child-
HLA class I antigens, soluble, in serum and synovial fluid from patients hood periodic fever with, 579
with rheumatoid arthritis and other arthropathies, 1365 Hypermobility (syndrome)
HLA class I] gene polymorphisms in antiphospholipid syndrome: haplotype living with the, (E) 487
analysis in 83 Caucasoid patients, 31 a national survey. British consultant rheumatologists’ perceptions about
HLA class II region in early rheumatoid arthritis. Evidence for a protective the, 559
role of the, 133 time to take seriously (in adults and children), (E) 485
HLA-B*51, lack of association of, with a severe disease course in Behe¢et’s see also Joint hypermobility
disease, 668 Hypoparathyroidism presenting as myopathy with raised creatine kinase,
HLA-DQ and interleukin 1%, increased endothelial expression of, in extra- (L) 1417
articular rheumatoid arthritis. Results from immunohistochemical stud- Hypophosphataemic osteomalacia, acquired,: the perils of missed a diagno-
ies of skeletal muscle, 1346 sis. A severe case of, (L) 707
HLA-DQBI CARI/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in
Tunisian patients with rheumatoid arthritis and Sjégren’s syndrome, IBSEN study. The prevalence and incidence of peripheral arthritis in patients
1370 with inflammatory bowel disease, a prospective population-based
HocHBERG M see Brooks P study, 1256
Hor_zer D see Moller B ICHIKAWA Y see Suzuki Y
Horspauek LC, KUHNe CA, Nies C, HeureLper AE. Identical twins with IgG subclass distribution of antibodies against §,-GPI and cardiolipin in
hypercalcaemia due to Lowe’s syndrome, (L) 107 patients with systemic lupus erythematosus and primary antiphospho-
HO6rcer E see Aringer M lipid syndrome, and their clinical associations, 1026
HormMan DM sce de Nijs RNJ IgG synthesis, intra-articular, in patients with Chlamydia trachomatis reactive
HOGENDOORN PCW see Ronday HK arthritis. Indirect evidence of, 801
Ho tuts S see Herrick Al; Wan MC IHARA K see Ahmed S
Homeopathy in rheumatoid arthritis. A randomized controlled trial of, 1052 IHN H, see Yamane K
Homocysteine modulation as a reason for continuous folic acid lina N see Nawata M
supplementation in methotrexate-treated rheumatoid arthritis patients, IKEDA K see Nawata M
(L) 715 IL see Interleukin
Honorati MC, MELICONE R, PULSATELLI L, CANE S, FRIZZiERO L, FACCHINI ILAR (International League of Associations for Rheumatology), regional
\. High in vivo expression of interleukin-17 receptor in synovial leagues and other groups. Outcome measures and classification criteria
endothelial cells and chondrocytes from arthritis patients, 522 for the rheumatic diseases. A compilation of data from OMERACT
HOrL WH sce Schmaldienst $ (Outcome Measures for Arthritis Clinical Trials), 896
Hormonal and immune systems in rheumatoid arthritis. The effects of ILLINGWORTH KJ see Herrick Al
exercise on the, 610 IMGRUND M, Warnatz K, Unt M, FeveRHAKE F, Peter H. EMO syndrome
Hoste G see Birrell I as a late explanation for pretibial swelling, (L) 357
HouBeNn HHM see de Nijs RNJ Immune and hormonal systems in rheumatoid arthritis. The effects of
HouTEN SM see Frenkel J exercise on the, 610
Howe_t K see Cherkas LF; Coleiro B Immune responses to collagen type I, II, 1V and V and Klebsiella pneumoniae
Hsien S-C, SUN K-H, Tsai C-Y, Tsat Y-Y, Tsar S-T, HUANG D-F, HAN in patients with Crohn’s disease and ankylosing spondylitis. Correlation
S-H, Yu H-S, Yu C-L. Monoclonal anti-doubie stranded DNA anti- between the, 15
body is a leucocyte-binding protein to up-regulate interleukin-8 gene Immunoadsorption, intravenous immunoglobulin application following,
expression and elicit apoptosis of normal human polymorphonucleat benefit or risk in patients with autoimmune diseases?, 513
neutrophils, 851 Immunogenetic profiles, cytokine and, in Japanese patients with adult Sull’s
Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic disease. Association with chronic articular disease, 1398
lupus erythematosus, 152 Immunoglobulins
ANG D-F see Hsieh S-C intravenous, and octreotide as treatment of intestinal pseudo-
ANG J see Inoue K obstruction revealing a recurrence of polymyositis, (L) 1072
GHES A see Filer A see also IgG
GHES GRV sce Caliz R: Godfrey T; Gordon PA INANC M see Gill A
GuET P see Solans R INDIVERI F see Filaci G
ISMAN AM see de Nijs RNJ Infection in febrile patients with systemic lupus erythematosus regardless of
IssoON AP see Wilson AS CRP levels. Pyrexia and normal C-reactive protein (CRP) in patients
KUDA S see Inoue K with systemic lupus erythematosus: always consider the possibility of,
LKKONEN J, PERTOVAARA M, ANTONEN J, PASTERNACK A, HURME M (L) 349
GENERAL INDEX
Inflammation in early rheumatoid arthritis, cytokines, metalloproteinases, Jaccoud’s arthropathy of the hands as a complication of pyrophosphate
their inhibitors and cartilage oligomeric matrix protein: relationship to arthropathy, (L) 354
radiological progression and, A 5-year prospective study, 544 Jacos AL see Maclachlan D
Inflammatory arthrides. The prevalence of Mycoplasma fermentans in Jacoss JWG see de Nijs RNJ
patients with, 1355 Jacoss R, PAWLAK CR, Mikeska E, MEYER-OLSON D, MartTIN M, HEWNEN
Inflammatory bowel disease, the prevalence and incidence of peripheral CJ, ScHEDLOwsKI M, ScuMibpT RE. Systemic lupus erythematosus and
arthritis in patients with, a prospective population-based study rheumatoid arthritis patients differ from healthy controls in_ their
(IBSEN ), 1256 cytokine pattern after stress exposure, 868
Inflammatory cytokine(s) JACOBSEN BK see Gran JT
production in fibroblast-like rheumatoid synoviocytes is independent Jacossson LTH see Turesson C
of nuclear factor-KB activation induced by tumour necrosis factor %. JAHNS R see Keberle M
Glucocorticoid-mediated repression of, 267 JAHNSEN J sce Palm O
in subchondral bone regions in the destructive joint of rheumatoid JAIN R see Hemmings FJ
arthritis. Expression of proteinases and, 247 JANSEN LMA see Tijhuis GJ
see also Cytokine(s) Jawap ASM. Re: NSAIDS and simple analgesics, (L) 945
Inflammatory disorders. Reactive haemophagocytic syndrome in children Jawap ASM see also Jawed S
with, a retrospective study of 24 patients, 1285 Jaweb S, JAwap ASM, Pabuiar N, Perry JD. Chronic exertional compart-
Infliximab. Treatment of recalcitrant orogential ulceration of Behcet's disease ment syndrome of the forearms secondary to weight training (L) 344
with, (L) 473 JEANSSON S see Shadidi KR
INGELMO M see Ramos-Casals M Jerreriss C see Walsh S$
INGLIS JT see Birmingham TB JEFFREY R see Wedderburn LR
INOUE A see Gotoh M Jenetr M see Keberle M
INoUE K, HuUkUDA S, FARDELLON P, YANG ZQ. NAKAI M, KATAYAMA K, JENVRIN C see Chevrel G
UsutyAMA T, SARUHASHI Y, HUANG J, Mayeba A, Catteppu I, OBRy JiNGUSHI S see Miyanishi K
C. Prevalence of large-joint osteoarthritis in Asian and Caucasian Jinks C, Lewis M, ONG BN, Crort P. A brief screening tool for knee pain
skeletal populations, 70 in primary care. 1. Validity and reliability, 528
INOUE K. Reply to letter from Rothschild B, (L) 1074 JOBANPUTRA P see Filer A
Interleukin | receptor antagonist (IL-]Ra) gene, a polymorphism within JOHNSTON RA see Hamilton JD
the, is associated with ankylosing spondylitis. 1359 Joint damage, bone turnover and bone mineral density in early rheumatoid
Interleukin Ix. increased expression of HLA-DQ and, in extra-articular arthritis treated with combination therapy including high-dose predniso-
rheumatoid arthritis. Results from immunohistochemical studies of lone, 1231
skeletal muscle, 1346 Joint destruction. Alternatively spliced EDA-containing fibronectin in
Interleukin-1 receptor antagonist, the effects of treatment with. on the synovial fluid as a predictor of rheumatoid, 739
inflamed synovial membrane in rheumatoid arthritis, 62 Joint, destructive, of rheumatoid arthritis. Expression of proteinases and
Interleukin-1-induced subacromial synovitis and shoulder pain in rotator inflammatory cytokines in subchondral bone regions in the, 247
cull diseases, 995 Joint hypermobility
Interleukin-6 plasma levels, elevated, are regulated by the promoter region benign, in childhood, (E) 489
of the /L6 gene in primary Sjégren’s syndrome and correlate with the pro-inflammatory interleukins in the synovial fluid of rheumatoid
clinical manifestations of the disease, 656 arthritis associated with, 202
Interleukin-6 promoter polymorphism (~ 174 G/C) in Caucasian German see also Hypermobility (syndrome)
patients with systemic lupus erythematosus, 393 Joint problems — how to manage demand. Royal College of General
Interleukin-8 gene expression and elicit apoptosis of normal human polymor- Practitioners and British Society for Rheumatology. A joint initiative
phonuclear neutrophils. Monoclonal anti-double stranded DNA anti- for, (L) 833
body is a leucocyte-binding protein to up-regulate, 851 Joint protection programme, educational-behavioural, for people with
Interleukin-10 production in children with extended oligoarticular juvenile rheumatoid arthritis. One-year outcomes of a randomized controlled
idiopathic arthritis. Hereditary predisposition to low, 574 trial of an, 1044
Interleukin-15, is elevated in systemic lupus erythematosus. Serum, 876 Joint space
Interleukin-16 with proinflammatory cytokines in patients with rheumatoid narrowing and erosive damage in hand X-rays of patients with rheuma-
arthritis. Correlation of circulating, (L) 474 toid arthritis. The relationship between soft tissue swelling, 297
Interleukin-17 receptor in synovial endothelial cells and chondrocytes from width in hip osteoporosis: influence of joint positioning and radio-
arthritis patients. High in vivo expression of, 522 graphic procedure. Measurement of, 414
Interleukin-18 and its monokine-directed function in rheumatoid arthritis. Jones MA see Chehata JC
I xpression of, 302 Jones PW see Chehata JC: Jordan K
Interleukins in the synovial fluid of rheumatoid arthritis associated with JONSSON R see Bowman SJ
joint hypermobility. Pro-inflammatory, 202 JORDAN GR see Walsh S
International Myositis Outcome Assessment Collaborative Study Group, JoRDAN K, Dziepzic K, MULLIs R, Dawes PT, Jones PW. The development
1262 of three-dimensional range of motion measurement systems for clinical
Internet-based rheumatology education (hhtp://rheuma.bham.ac.uk). practice, (E) 1081
Provision of, 645 JOUEN-BEADES F see Vittecog O
Interstitial lung disease in patients with rheumatoid arthritis: a comparison Jowett RL see Madan S
with cryptogenic fibrosing alveolitis, 1022 Juvenile arthritis, measuring the function of children with, 1274
Interstitial pneumonitis and air leakage in juvenile dermatomyositis, 588 Juvenile (onset) dermatomyositis
Intestinal bypass syndrome 18 yrs after initial surgery. First presentation of, central nervous system complications in two cases of, 1293
(L) 351 interstitial pneumonitis and air leakage in, 588
Intestinal pseudo-obstruction revealing a recurrence of polymyositis. pulmonary involvement in,: a two-year longitudinal study, 216
Intravenous immunoglobulins and octreotide as treatment of. (L) 1072 Juvenile idiopathic arthritis
Intravenous immunoglobulin application following immunoadsorption: associated with autoimmune thyroid disorders and autoimmune cholan-
benefit or risk in patients with autoimmune diseases?, 513 gitis, 942
Intravenous immunoglobulin. Successful treatment of ‘malignant rheuma- discordance between proxy-reported and observed assessment of func-
toid arthritis’ in Japan with pooled. (L) 955 tional ability of children with, 914
IrtsA T see Miyanishi K efficacy and safety profile of cyclosporin A in the treatment of, results
Isaacs JD. From bench to bedside: discovering rules for antibody design, of a 10-year prospective study, 907
and improving serotherapy with monoclonal antibodies, 724 hereditary predisposition to low interleukin-10 production in children
IspALE AH sce Knighis LR with extended oligoarticular, 574
ISENBERG DA see Dodds WN: Miller FW: Moss KE: Price EJ: Ravirajan outcome status in children with sustained polyarticular and systemic,
CT; Sutcliffe N 225
ISHIGATSUBO Y see Ohno M proposed preliminary core set measures for disease Outcome assessment
IStoK R, Czi1RJAK L, LUKAC J, STANCIKOVA M, ROveNSKY. Increased urinary in adult and, myopathies, 1262
pyridinoline cross-link compounds of collagen in patients with systemic stress fractures: diagnostic pitfalls in, 1313
sclerosis and Raynaud’s phenomenon, 140 uveitis in sibling pairs with, 221
IUCDs. Polymyalgia rheumatica and. (L) 347 Juvenile idiopathic inflammatory myopathies. Persistent maternally derived
IWAMATO Y see Miyanishi K peripheral microchimerism is associated with the, 1279